Showing results (1351-1360 of 1,437) with videos related to

Sort By:
Pageof 144
Neoplasia (New York, N.Y.)|October 26, 2012
Role of transcriptional corepressor CtBP1 in prostate cancer progressionRui Wang, Irfan A Asangani, Balabhadrapatruni V S K Chakravarthi, et al.
The Journal of Experimental Medicine|May 5, 2022
Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancerRenuka Raman, Jacques A Villefranc, Timothy M Ullmann, et al.
Cancer Research|March 1, 2005
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer riskGoutham Narla, Analisa Difeo, Helen L Reeves, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2012
Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer riskFrancesca Demichelis, Sunita R Setlur, Samprit Banerjee, et al.
NPJ Precision Oncology|July 11, 2026
Aurora kinase A is a synthetic lethal target in FANCA-deficient cancersDilara Akhoundova, Martín González-Fernández, Aavash Baral, et al.
Nature Communications|November 4, 2020
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticityJoanna Cyrta, Anke Augspach, Maria Rosaria De Filippo, et al.
JAMA Oncology|May 19, 2017
Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate CancerMartin G Sanda, Ziding Feng, David H Howard, et al.
Nature Communications|June 21, 2018
Patient derived organoids to model rare prostate cancer phenotypesLoredana Puca, Rohan Bareja, Davide Prandi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2007
Assessing the significance of chromosomal aberrations in cancer: methodology and application to gliomaRameen Beroukhim, Gad Getz, Leia Nghiemphu, et al.
JCO Precision Oncology|January 16, 2018
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical ModelsDavid J Pisapia, Steven Salvatore, Chantal Pauli, et al.
Pageof 144